FDA Authorizes Broad Use Of Tamiflu And Relenza To Deal With Swine Flu Outbreak

Emergency Use Authorizations for Roche and GSK products facilitate distribution to wider population, including alternate dosing or use by individuals outside approved labeling. FDA’s Sharfstein testifies before Congress April 30.